Navigation Links
Pelosi Remarks at amfAR Conference on Future Directions in Fight Against HIV/AIDS
Date:5/13/2009

WASHINGTON, May 13 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi received an "Award of Courage" from amfAR at the research foundation's conference today on future directions in the fight against HIV/AIDS. amfAR's "Awards of Courage" are bestowed each year on select individuals in recognition of the vision, determination, and courage that mark them as leaders in the fight against AIDS. Other 2009 awardees are Senator Edward Kennedy, Dr. C. Everett Koop and Earvin "Magic" Johnson. Below are the Speaker's remarks as prepared:

"Thank you, Kenneth Cole, for that kind introduction. And thank you to amfAR for the 2009 amfAR Award of Courage.

"I am honored to be receiving this award along with three respected leaders in the fight against HIV/AIDS:

  • Senator Edward M. Kennedy, whose forceful advocacy in the Senate for people living with HIV/AIDS helped invest federal research dollars to confront this crisis and created our existing system of care and treatment through enactment of the Ryan White CARE Act;
  • Dr. C. Everett Koop, whose efforts in the very early days helped educate Americans about the risks of HIV/AIDS and about sensible prevention efforts; and,
  • Magic Johnson, whose 1991 announcement that he was living with HIV showed the world his enormous courage, and whose philanthropy and AIDS advocacy have revealed his remarkable compassion.

"America and the world owe amfAR a debt of gratitude for your nearly quarter-century history of advancing HIV prevention, treatment and care. Your work has saved lives, achieved dignity for those living with the disease, and advanced research that is bringing help and hope to those with HIV/AIDS.

"Moments like this bring me back to my first day in Congress - and remind me to honor those who have helped us make phenomenal progress in the fight against HIV/AID
'/>"/>

SOURCE Office of the Speaker of the House
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Pelosi: SCHIP Bill a Giant Step for Americas Children
2. Pelosi Statement on Proposed Entitlement Task Force
3. Pelosi: Todays Sweeping, Bipartisan Legislation to Improve Drug Safety is a Victory for All Americans
4. Pelosi, Slaughter and Tubbs Jones Introduce Health Tracking Legislation
5. Pelosi: Mr. President - Drop the Partisan Rhetoric, Put Down the Veto Pen
6. Pelosi: Tonights Strong Bipartisan Vote for Childrens Health Insurance a Victory for Americas Children
7. Pelosi Statement on House Vote to Extend Family and Medical Leave for Military Families
8. Pelosi and Reid: Congress Sends President Bush Bipartisan Childrens Health Insurance Bill
9. Pelosi Statement on National Breast Cancer Awareness Month
10. Pelosi: We Remain Committed to Making SCHIP Into Law - With or Without the Presidents Support
11. Pelosi: This Week, Members Must Choose Between Partisan Obstruction and Health Insurance for 10 Million Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)WASHINGTON, Dec. 5 ,, What: Cuts for a Cause ,, Why: To make a difference in the fight against cancer and other terminal illnesses affecting children. All proceeds from each hair service given
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2
...daq: XTNT ) today reported financial results for ...7., The company reported a net loss and net loss ...on, or $0.52 per share, for the fourth quarter,of ...mpany,s net loss per share attributable to common ...
... same results, analysis shows , , TUESDAY,...cular advantage to any single treatment for acute ...ion that carries with it a high risk of death, Can...or another, according to a report in the Feb. 20 ...
... way to spot hearing problems, study finds, , ...s may not just be a window to the soul, they may a...r senses. , A new study reports that the eyes can ... young children and in people who can,t actively t...
...tive isotopes for peacetime uses at Oak Ridge Nati...al Historic Chemical Landmark by the American Chem...enn., on March 6. , Bruce E. Bursten, Ph.D., pre...s, which began in 1946, demonstrated the peaceful ...
... Hospital, WALLA WALLA, Wash., Feb. 19 Secretary...today the Department of,Veterans Affairs (VA) will...on facility focused on mental health at the Walla ...ortance of mental,health as an issue for our veter...
...ered physical or sexual abuse as children spend up...ts, according to a long-term study of more than 3,...these women used health services at significantly ...quences from abuse that occurred decades ago, said...
Other Medicine News:Health News:XTENT Announces 2007 Financial Results 2Health News:XTENT Announces 2007 Financial Results 3Health News:XTENT Announces 2007 Financial Results 4Health News:XTENT Announces 2007 Financial Results 5Health News:XTENT Announces 2007 Financial Results 6Health News:No Difference Found in Treatments for Acute Kidney Failure 2Health News:No Difference Found in Treatments for Acute Kidney Failure 3Health News:Eyes a Window to Hearing Loss? 2Health News:Eyes a Window to Hearing Loss? 3Health News:Peacetime use of radioisotopes at Oak Ridge cited as Chemical Landmark 2Health News:Peacetime use of radioisotopes at Oak Ridge cited as Chemical Landmark 3Health News:Women who suffered child abuse spend more on health care 2Health News:Women who suffered child abuse spend more on health care 3
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4drugstore com Continues Global Sales Expansion to More Than 3 5 Billion International Consumers 62432 1drugstore com Continues Global Sales Expansion to More Than 3 5 Billion International Consumers 62432 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 15043 1Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 15043 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 15043 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 15041 1Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 15041 2
...acell Corporation,(Nasdaq: ACEL ) today announced...eutics (2008; 7(7):1871-9) reports that a combinat...ione antidiabetic drug rosiglitazone,shows a promi...of,PI3K-dependent Fra-1 expression or Survivin., ...earch conducted at,the University of Vermont in Bu...
...cal Course of Alzheimer,s Disease; Patients, Exper...emory and Thinking, Activities of Daily Livin..., July 17 Medivation, Inc.,(Nasdaq: MDVN ) today...,Alzheimer,s disease pivotal clinical trial of the... issue of The Lancet. In this double-blind,placebo...
Other Medicine Technology:Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines 2Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines 3Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease 2Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease 3Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease 4Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease 5
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: